ALFA Finder
15:44 IST
BSE
Board Meeting Date
Molbio Diagnostics Board Meeting Date
Molbio Diagnostics' Board is scheduled for November 5, 2026, to approve Q1 and H1 results. Trading window stays closed until 48 hours post-declaration.
Molbio Diagnostics Ltd
- Share price
- ₹1,318.60
- Market cap
- ₹15,196 Cr
- Revenue (annual)
- ₹1,446 Cr
- Net profit (annual)
- ₹166.6 Cr
- P/E (TTM)
- 98.4×Sector 54.5×
- Promoter holding
- 41.29%
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Earnings Call 4Financial Results 2Capital Structure Change 2Board Meeting Date 2Results Update 1Price Movement Clarification 1Board Meeting Outcome 1
Time
2 announcements with these filters
19:11 IST
NSE
Board Meeting Date
Molbio Diagnostics Board Meeting Date
Molbio Diagnostics Limited scheduled a board meeting for September 5, 2026, to approve the unaudited standalone and consolidated financial results for the June 2026 quarter.